29 participants
A Study to Evaluate the Effect of Mild and Moderate Hepatic Impairment on the Single-Dose Pharmacokinetics of Rilzabrutinib (PRN1008)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-06-05
- Start Date:
- 2020-11-02
- Completion:
- 2021-03-23
Conditions
- Hepatic Function Abnormal
- Healthy Volunteers
Interventions
- DRUG
No Results Yet